Bamboos Health Care Holdings Limited (2293) has issued a notice regarding its annual general meeting (AGM), set to take place on 28 November 2025 at 11:00 a.m. The meeting venue is Unit 801, 8/F, Good Hope Building, No. 612–618 Nathan Road, Mong Kok, Kowloon, Hong Kong.

The notice indicates that shareholders will review and approve the audited consolidated financial statements for the year ended 30 June 2025, along with the corresponding reports of the directors and auditor. Several re-election proposals are on the agenda, including the re-election of one executive director and two independent non-executive directors, together with an authorization for the board to fix the directors’ remuneration.

A resolution to re-appoint HLB Hodgson Impey Cheng Limited as the auditor for the year ending 30 June 2026 is also planned, accompanied by an authorization for the board to determine the auditor’s remuneration. Shareholders will consider approving a final dividend for the year ended 30 June 2025.

Additionally, the board seeks general mandates relating to share allotment, issuance, and buy-back. These include permission to allot additional shares up to 20% of the total number of shares in issue and a buy-back mandate of up to 10%, with the possibility of adding the bought-back shares to the general allotment mandate. Shareholders are advised to refer to the formal notice for details on proxy arrangements and other relevant procedures.